Jump to content

Oxford Nanopore: Difference between revisions

From Nanopore Wiki
Marked this version for translation
Expand Nanopore Wiki source page with structured educational content
Line 1: Line 1:
__NOTOC__
<translate>
<translate>
= Oxford Nanopore = <!--T:1-->
<!--T:1-->
[[File:Nanopore_sequencing_principle.png|thumb|right|320px|Nanopore sequencing principle. Openly licensed schematic used as a general visual guide.]]
'''Oxford Nanopore''' is part of the Nanopore Wiki learning path. Oxford Nanopore Technologies develops nanopore sequencing instruments, flow cells, chemistry, and software for real-time DNA and RNA sequencing.


<!--T:2-->
<!--T:2-->
'''Oxford Nanopore Technologies''' is a company known for commercial nanopore sequencing platforms and related software workflows.
== Core concepts ==
* The platform reads electrical signals produced as molecules pass through nanopores.
* Device families include portable and higher-throughput instruments.
* Output can include raw signal files, basecalled reads, alignments, and analysis reports.
* Performance depends on chemistry, flow cell quality, library preparation, basecaller model, and analysis settings.


== Context == <!--T:3-->
<!--T:3-->
== Typical sequencing workflow ==
{| class="wikitable np-knowledge-table"
! Step
! Description
|-
| 1
| Prepare DNA or RNA library according to the assay.
|-
| 2
| Load library onto a flow cell and start sequencing.
|-
| 3
| Basecall raw signal into sequence reads and quality scores.
|-
| 4
| Run quality control, alignment, assembly, variant calling, modification calling, or classification.
|}


<!--T:4-->
<!--T:4-->
Its platforms are often discussed in nanopore sequencing because they support portable sequencing, long reads, and real-time analysis.
== Typical applications ==
* Long-read genome sequencing.
* Metagenomics and pathogen surveillance.
* Transcriptomics and direct RNA sequencing.
* Structural variant and modification detection.


== Related pages == <!--T:5-->
<!--T:5-->
== Common pitfalls ==
* Comparing results without chemistry and model versions.
* Ignoring read quality, pore count, run yield, and sample degradation.
* Presenting research use as clinical guidance without validation.


<!--T:6-->
<!--T:6-->
== Related pages ==
* [[MinION]]
* [[Nanopore sequencing]]
* [[Nanopore sequencing]]
* [[MinION]]
* [[Bioinformatics]]
* [[Bioinformatics]]
* [[Platforms]]


== External links == <!--T:7-->
<!--T:7-->
 
== References ==
<!--T:8-->
* [https://en.wikipedia.org/wiki/Oxford_Nanopore_Technologies Oxford Nanopore Technologies]
* [https://nanoporetech.com/ Oxford Nanopore Technologies]
* [https://nanoporetech.com/ Oxford Nanopore Technologies official site]
</translate>
</translate>


<languages />
<languages />

Revision as of 10:12, 30 June 2026

Nanopore sequencing principle. Openly licensed schematic used as a general visual guide.

Oxford Nanopore is part of the Nanopore Wiki learning path. Oxford Nanopore Technologies develops nanopore sequencing instruments, flow cells, chemistry, and software for real-time DNA and RNA sequencing.

Core concepts

  • The platform reads electrical signals produced as molecules pass through nanopores.
  • Device families include portable and higher-throughput instruments.
  • Output can include raw signal files, basecalled reads, alignments, and analysis reports.
  • Performance depends on chemistry, flow cell quality, library preparation, basecaller model, and analysis settings.

Typical sequencing workflow

Step Description
1 Prepare DNA or RNA library according to the assay.
2 Load library onto a flow cell and start sequencing.
3 Basecall raw signal into sequence reads and quality scores.
4 Run quality control, alignment, assembly, variant calling, modification calling, or classification.

Typical applications

  • Long-read genome sequencing.
  • Metagenomics and pathogen surveillance.
  • Transcriptomics and direct RNA sequencing.
  • Structural variant and modification detection.

Common pitfalls

  • Comparing results without chemistry and model versions.
  • Ignoring read quality, pore count, run yield, and sample degradation.
  • Presenting research use as clinical guidance without validation.

References